Disappearance Rates of Coagulation Factors: Transfusion Studies in Factor‐Deficient Patients

Data are presented describing the circulating levels of coagulation factors after transfusion of blood and plasma into patients with deficiencies of factors V, VII, VIII, IX, and X. The half‐disappearance times of the factors were as follows: V, 16 hours; VII, 4 hours initially and 22.6 hours subsequently; VIII, 10.5 to 11 hours; IX, 4 hours initially, 39.5 hours subsequently; X, two components, the slower being 35 hours. All of the factors had an initial rapid disappearance with half‐disappearance times of a few hours. For factors VII, IX, and X, a two‐component logarithmic decrease was found. It is emphasized that, if these coagulation factors are proteins, they have half‐disappearance times which are considerably shorter than those of most other plasma proteins. The therapeutic implication of this observation is discussed in relation to hemostatic levels and survival of the coagulation factors in banked blood.

[1]  P. Owren,et al.  Surgery in a patient with factor V (proaccelerin) deficiency. , 2009, Acta medica Scandinavica.

[2]  M. Blombäck,et al.  On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. , 2009, Acta medica Scandinavica.

[3]  H. Horowitz,et al.  Survival of Factor XI in Vitro and in Vivo , 1965, Transfusion.

[4]  R. Rosenthal,et al.  PTA (factor XI) levels and coagulation studies after plasma infusions in PTA-deficient patients. , 1965, The Journal of laboratory and clinical medicine.

[5]  F. Kazmier,et al.  EFFECT OF ORAL ANTICOAGULANTS ON FACTORS VII, IX, X, AND II. , 1965, Archives of internal medicine.

[6]  H. Hemker,et al.  The Biological Half-Time of Hageman Factor , 1965, Thrombosis and Haemostasis.

[7]  H. Roberts,et al.  HEMOSTASIS IN FACTOR V DEFICIENCY , 1964, The American journal of the medical sciences.

[8]  V. Marder,et al.  CLINICAL ASPECTS OF CONGENITAL FACTOR VII DEFICIENCY. , 1964, The American journal of medicine.

[9]  Massouras Hg,et al.  RESPIRATION AND THE CEREBROSPINAL FLUID. , 1964 .

[10]  Pool Jg,et al.  HIGH-POTENCY ANTIHAEMOPHILIC FACTOR CONCENTRATE PREPARED FROM CRYOGLOBULIN PRECIPITATE. , 1964 .

[11]  R. Gage,et al.  CONGENITAL DEFICIENCY OF FACTOR VII (HYPOCONVERTINEMIA). CRITICAL REVIEW OF LITERATURE AND REPORT OF THREE CASES, WITH EXTENSIVE PEDIGREE STUDY AND EFFECT OF TRANSFUSIONS. , 1964, The American journal of medicine.

[12]  O. Prou-Wartelle,et al.  Demi-vie de la prothrombine vraie (facteur II) , 1964 .

[13]  J. Niemetz,et al.  Blood PTA (Factor XI) Levels Following Plasma Infusion.∗ , 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[14]  E. Bowie,et al.  THE STABILITY OF ANTIHEMOPHILIC GLOBULIN AND LABILE FACTOR IN HUMAN BLOOD. , 1964, Mayo Clinic proceedings.

[15]  R. Biggs,et al.  The Fate of Prothrombin and Factors VIII, IX and X Transfused to Patients Deficient in these Factors , 1963, British journal of haematology.

[16]  E. Adelson,et al.  The survival of factor VIII (antihemophilic globulin) and factor IX (plasma thromboplastin component) in normal humans. , 1963, The Journal of clinical investigation.

[17]  R. Biggs,et al.  The Treatment of Haemorrhage in von Willebrand's Disease and the Blood Level of Factor VIII (AHG) , 1963, British journal of haematology.

[18]  J. Caen,et al.  Transfusion Studies in von Willebrand's Disease: Effect on Bleeding Time and Factor VIII , 1963, British journal of haematology.

[19]  A. Hensen,et al.  Substitution Therapy in Haemophilia B , 1961, Thrombosis and Haemostasis.

[20]  C. Mcmillan,et al.  A study of fibrinogen turnover in classical hemophilia and congenital afibrinogenemia. , 1961, Blood.

[21]  V. Donaldson Bleeding Syndromes: A Clinical Manual , 1961 .

[22]  P. M. Aggeler Physiological Basis for Transfusion Therapy in Hemorrhagic Disorders: A Critical Review , 1961, Transfusion.

[23]  J. Graham,et al.  Plasma Thromboplastin Component (Christmas Factor, Factor IX) Levels in Stored Human Blood and Plasma , 1960, Thrombosis and Haemostasis.

[24]  M. Hoag,et al.  Disappearance rate of concentrated proconvertin extracts in congenital and acquired hypoproconvertinemia. , 1960, The Journal of clinical investigation.

[25]  C. Owen,et al.  Soybean phosphatides in prothrombin-consumption and thromboplastin-generation tests: their use in recognizing "thrombasthenic hemophilia". , 1960, American journal of clinical pathology.

[26]  van der Esch,et al.  Factor VII: its Turnover Rate and its Possible Role in Thrombogenesis , 1960, Thrombosis and Haemostasis.

[27]  C. Borchgrevink,et al.  A Study of a Case of Congenital Hypoprothrombinaemia , 1959, British journal of haematology.

[28]  J. Soulier,et al.  Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man. , 1959, The Journal of laboratory and clinical medicine.

[29]  Douglas As Antihemophilic globulin assay following plasma infusions in hemophilia. , 1958 .

[30]  R. Macmillan,et al.  A MODIFICATION OF THE THROMBOPLASTIN GENERATION TEST , 1958, The American journal of the medical sciences.

[31]  R. Biggs Assay of antihaemophilic globulin in treatment of haemophilic patients. , 1957, Lancet.

[32]  R. G. Macfarlane,et al.  Surgery in haemophilia; the use of animal antihaemophilic globulin and human plasma in thirteen cases. , 1957, Lancet.

[33]  J. Case,et al.  The stability of Christmas factor; a guide to the management of Christmas disease. , 1956, Lancet.

[34]  C. A. Owen,et al.  Evaluation of disorders of blood coagulation in the clinical laboratory. , 1955, American journal of clinical pathology.

[35]  C. A. Owen,et al.  Dextran as a substitute for acacia in assay of plasma prothrombin. , 1955, American journal of clinical pathology.

[36]  S. Creveld Congenital Idiopathic Hypoprothrombinemia 1 , 1954, Acta paediatrica. Supplementum.

[37]  D. Gitlin,et al.  Studies on the metabolism of fibrinogen in two patients with congenital afibrinogenemia. , 1953, Blood.

[38]  A. S. Douglas,et al.  The Thromboplastin Generation Test , 1953, Journal of clinical pathology.

[39]  A. S. Douglas,et al.  The Measurement of Prothrombin in Plasma , 1953, Journal of clinical pathology.

[40]  B. Alexander,et al.  Parahemophilia in three siblings (Owren's disease). , 1952, The American journal of medicine.

[41]  E. Frank,et al.  Die Parahämophilie (Owren), eine neue Form der hämorrhagischen Diathese , 1950 .

[42]  A. Quick,et al.  The prothrombin consumption test; its clinical and theoretic implications. , 1949, Blood.

[43]  A. Quick On the quantitative estimation of prothrombin. , 1945, American journal of clinical pathology.

[44]  E. Warner,et al.  A QUANTITATIVE STUDY ON BLOOD CLOTTING: PROTHROMBIN FLUCTUATIONS UNDER EXPERIMENTAL CONDITIONS , 1936 .

[45]  E. E. Ecker,et al.  AN IMPROVED METHOD FOR COUNTING BLOOD PLATELETS , 1923 .

[46]  W. Crofton Section of medicine , 1921 .

[47]  W. W. Duke The Relation of Blood Platelets to Hemorrhagic Disease: Description of a Method for Determining the Bleeding Time and Coagulation Time and Report of Three Cases of Hemorrhagic Disease Relieved by Transfusion , 1910 .

[48]  [Fibrin stabilizing factor (FSF)]. , 1968, Il Policlinico. Sezione pratica.

[49]  P. Hjort,et al.  Turnover of prothrombin, factor VII and factor IX in a patient with hemophilia A. , 1961, Scandinavian journal of clinical and laboratory investigation.

[50]  J. Graham Stuart clotting defect and Stuart factor. , 1960, Thrombosis et diathesis haemorrhagica.

[51]  Graham Jb Stuart clotting defect and Stuart factor. , 1960 .

[52]  F. Duckert On the properties of the Stuart-Prower factor. , 1960, Thrombosis et diathesis haemorrhagica.

[53]  A. S. Douglas Antihemophilic globulin assay following plasma infusions in hemophilia. , 1958, The Journal of laboratory and clinical medicine.

[54]  P. Frick Studies on the turnover rate of stable prothrombin conversion factor in man. , 1958, Acta haematologica.

[55]  J. Wilkinson,et al.  Changes in the blood-clotting defect in Christmas disease after plasma and serum transfusions. , 1958, Clinical science.

[56]  K. Brinkhous,et al.  Physiologic basis of transfusion therapy in hemophilia. , 1956, A.M.A. archives of pathology.

[57]  N. W. Barker,et al.  The determination of prothrombin time following the administration of dicumarol, 3,3'-methylenebis (4-hydroxyconmarin), " with special reference to thromboplastin. , 1945 .